Complications of Hyaluronic Acid Fillers: Recognition, Prevention, and Management

Conclusions

• Serious complications after dermal fillers are uncommon but clinically important, especially because some outcomes such as blindness and tissue necrosis can be permanent and devastating.
• The most important drivers of filler complications are inadequate anatomy knowledge, technique errors, poor product selection, and failures in aseptic practice.
• Vascular compromise is the most urgent complication, and early recognition of severe pain, blanching, reticulated erythema, and dusky discoloration is critical to preventing tissue loss.
• High-risk facial areas for vascular events include the glabella, forehead, nose, nasolabial folds, and temporal region, so injections in these zones require extra caution or avoidance.
• Complication risk is reduced by slow, low-pressure injections, small aliquots, careful depth selection, and frequent use of cannulas when appropriate.
• If vascular occlusion is suspected, treatment should begin immediately with stopping the injection, warm compresses and massage, hyaluronidase rescue, and escalation to appropriate specialists when needed.
• Delayed nodules are usually immune mediated and may be associated with specific filler technologies, so persistent lumps weeks to months after injection should be treated as a distinct inflammatory complication.
• Biofilm-related reactions can mimic other nodules, often have negative cultures, and are best prevented with strict asepsis, minimizing punctures, avoiding mucosal entry, and avoiding permanent fillers.
• Granulomas and foreign-body reactions require differentiation from infection and other delayed complications because management differs and may include hyaluronidase, steroids, 5-FU, or excision.
• Overall, the presentation concludes that safe filler practice depends on anatomy-based risk reduction, appropriate patient and product selection, and rapid rescue protocols for early complication management.